Anatomy of an Epidemic investigates a medical mystery: Why has the number of adults and children disabled by mental illness skyrocketed over the past fifty years? There are now more than four million people in the United States who receive a government disability check because of a mental illness, and the number continues to soar. Every day, 850 adults and 250 children with a mental illness are added to the government disability rolls. What is going on?


Anatomy of an Epidemic reviews the scientific literature to investigate the long-term effects of psychiatric medications. These documents provide access to the abstracts (or complete articles) referred to in the book.

Antipsychotics / Schizophrenia
Benzodiazepines / Anxiety
Antidepressants / Depression
Polypharmacy / Bipolar Disorder
Psychotropics / Pediatric Disorders


Videos from a conference in Copenhagen, Denmark. Recorded on May 14, 2014.

Part I: Roots of the Epidemic
Part II: Long-term Effects of Psych Drugs
Part IV: Psych Drugs and Children
Part V: Q & A with Peter Gotzsche


Robert Whitaker’s slide presentations on the long-term effects of psychiatric medications for major mental disorders in adults, and on the “evidence-base” for the prescribing of psychiatric drugs to children.


Anatomy of an Epidemic: The History and Science of a Failed Paradigm of Care
Vancouver, Canada
April 2016

Rethinking the Use of Psychiatric Drugs
London, UK
November 2016

Psychiatry Under the Influence:
University of Texas Rio Grande Valley
April 2016

Affective Disorders

Affective Disorders in the Age of Prozac
Santiago, Spain
May, 2016

Causation Not Just Correlation: Disability in the Age of Prozac
U.K. Parliamentary Work Group
May 2016


The Case Against Antipsychotics
McGill Medical School Grand Rounds
September 2016

Pediatric Disorders

Medicating Children: Science, Commerce, and Long-term Outcomes
NYU Conference
September 2016

Medicating Children: When Long-term Outcomes Are Considered, Is This an Evidence-Based Practice?
Santiago, Spain
May, 2016

Medicating ADHD: If Long-term Outcomes Are Considered, Is This an Evidence-based Practice?


Antipsychotics in Open Dialogue Therapy: A Best Use Model of Care